The Jesse Z and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
Diabetes Technol Ther. 2021 Feb;23(2):146-154. doi: 10.1089/dia.2020.0375. Epub 2020 Sep 28.
The increasing prevalence of diabetes, combined with a growing global shortage of health care professionals (HCP), necessitates the need to develop new approaches to diabetes care delivery to expand access to care, lessen the burden on people with diabetes, improve efficiencies, and reduce the unsustainable financial liability on health systems and payers. Use of digital diabetes technologies and telehealth protocols within a digital/virtual diabetes clinic has the potential to address these challenges. However, several issues must be resolved to move forward. In February 2020, organizers of the Advanced Technologies & Treatments for Diabetes Annual Conference convened an international panel of HCP, researchers, patient advocates, and industry representatives to review the status of digital diabetes technologies, characterize deficits in current technologies, and identify issues for consideration. Since that meeting, the importance of using telehealth and digital diabetes technologies has been demonstrated amid the global coronavirus disease (COVID-19) pandemic. This article summarizes the panel's discussion of the opportunities, obstacles, and requisites for advancing the use of these technologies as a standard of care for the management of diabetes.
糖尿病的发病率不断上升,加上全球医疗保健专业人员(HCP)的短缺,这就需要开发新的糖尿病护理提供方式,以扩大护理的可及性,减轻糖尿病患者的负担,提高效率,并减轻卫生系统和支付方的不可持续的财务负担。在数字化/虚拟糖尿病诊所中使用数字糖尿病技术和远程医疗协议有可能解决这些挑战。然而,要想取得进展,还必须解决几个问题。2020 年 2 月,糖尿病先进技术与治疗年度会议的组织者召集了一个由 HCP、研究人员、患者权益维护者和行业代表组成的国际小组,审查数字糖尿病技术的现状,确定当前技术的不足,并确定需要考虑的问题。自那次会议以来,在全球冠状病毒病(COVID-19)大流行期间,远程医疗和数字糖尿病技术的重要性得到了证明。本文总结了该小组对推进这些技术的使用的机会、障碍和必要条件的讨论,这些技术是糖尿病管理的护理标准。